title: Interaction of botulinum toxin type A with local anesthetic agents: an experimental study with rabbits.
abstract: Injection of botulinum toxin is a painful procedure, limiting the number of patients treated. This study was designed to establish whether infiltration of local anesthetics plays a role in the effectiveness of botulinum toxin. For the study, 24 New Zealand white rabbits were divided into three groups. In all three groups, local anesthetics (prilocaine, lidocaine, lidocaine, and epinephrine) were injected into the right anterior auricular muscle before a 2.5-U injection of botox A. The contralateral anterior auricular muscle of all the rabbits was injected with the same dose of the toxin to serve as a control. Photographic documentation was recorded; electromyographic study was performed; and results were statistically analyzed. The results show that local anesthetics do not play a role in the efficacy of botulinum toxin. Thus, the use of infiltrative local anesthetics before botulinum toxin injection is a safe method for achieving a less painful procedure for the patient.
authors.affiliation: Ataturk Training and Research Hospital, Izmir, Turkey.
authors.forename: Metin
authors.initials: M
authors.lastname: Görgü
authors.forename: Ozlem Karataş
authors.initials: OK
authors.lastname: Silistreli
authors.forename: Burçe
authors.initials: B
authors.lastname: Karantinaci
authors.forename: Meltem
authors.initials: M
authors.lastname: Ayhan
authors.forename: Tolga
authors.initials: T
authors.lastname: Ozdemirkiran
authors.forename: Mehmet
authors.initials: M
authors.lastname: Celebisoy
mesh_terms: D000779:Anesthetics, Local / Q000494:pharmacology* / Q000627:therapeutic use*; D000818:Animals; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism*; D004576:Electromyography; D007279:Injections, Subcutaneous; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*; D011343:Procaine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D011817:Rabbits; D013748:Tetracaine / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000779:Anesthetics, Local; D009465:Neuromuscular Agents; D013748:Tetracaine; D011343:Procaine; C004616:chloroprocaine; D019274:Botulinum Toxins, Type A